×
About 275 results

ALLMedicine™ Vascular Ehlers-Danlos Syndrome Center

Research & Reviews  104 results

Nonsyndromic arteriopathy and aortopathy and vascular Ehlers-Danlos syndrome causing CO...
https://doi.org/10.1002/ajmg.a.62774
American Journal of Medical Genetics. Part A; Yagi H, Takeda N et. al.

May 12th, 2022 - Vascular Ehlers-Danlos syndrome (vEDS) is an autosomal dominant genetic disorder characterized by soft connective tissue vulnerability due to dysfunction of Type III collagen and caused by the pathogenic variants in COL3A1 gene. In the era of next...

Hemothorax and Bloody Ascites Caused by Vascular Ehlers-Danlos Syndrome.
https://doi.org/10.1016/j.amjmed.2022.02.042
The American Journal of Medicine; Tanaka S, Honda H et. al.

Mar 24th, 2022 - Hemothorax and Bloody Ascites Caused by Vascular Ehlers-Danlos Syndrome.|2022|Tanaka S,Honda H,Hasegawa K,Tomita K,Sogawa R,|

Multiple Spontaneous Coronary Artery Dissections and Ruptures in Vascular Ehlers-Danlos...
https://doi.org/10.1253/circj.CJ-21-1083
Circulation Journal : Official Journal of the Japanese Ci... Fukuhara K, Otowa K et. al.

Mar 18th, 2022 - Multiple Spontaneous Coronary Artery Dissections and Ruptures in Vascular Ehlers-Danlos Syndrome.|2022|Fukuhara K,Otowa K,Chikata A,Maruyama M,Usuda K,|

Comparative therapeutic strategies for preventing aortic rupture in a mouse model of va...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926273
PLoS Genetics; Legrand A, Guery C et. al.

Mar 5th, 2022 - Vascular Ehlers-Danlos syndrome is a rare inherited disorder caused by genetic variants in type III collagen. Its prognosis is especially hampered by unpredictable arterial ruptures and there is no therapeutic consensus. We created a knock-in Col3...

Safety and Effectiveness of TEVAR in Native Proximal Landing Zone 2 for Chronic Type B ...
https://doi.org/10.1177/15266028211061276
Journal of Endovascular Therapy : an Official Journal of ... Eleshra A, Panuccio G et. al.

Dec 14th, 2021 - The aim of this study is to report the safety and effectiveness of thoracic endovascular aortic repair (TEVAR) in a native proximal landing zone (PLZ) 2 for chronic type B aortic dissection (TBAD) patients with genetic aortic syndrome (GAS). A ret...

see more →

Clinicaltrials.gov  1 results

Study of Arterial Properties by Ultra-high Frequency Ultrasound in Fibromuscular Dysplasia and Vascular Ehlers-Danlos Syndrome
https://clinicaltrials.gov/ct2/show/NCT03596437

Mar 13th, 2019 - Background: Fibromuscular dysplasia (FMD) is an idiopathic, systemic, non-atherosclerotic, non-inflammatory vascular disease leading to stenosis, aneurysms, dissections and occlusion of small and medium-sized arteries, with possible life-threateni...

see more →

News  4 results

Morning Break: AMA Sues N.D.; Cardiologist's Murder; Judges Guilty on Opioids?
https://www.medpagetoday.com/painmanagement/opioids/80705

Jun 26th, 2019 - Note that some links may require subscriptions. The American Medical Association filed suit to block North Dakota's new law requiring physicians to give "misleading or even patently false, non-medical information" to women asking about abortion. H...

FDA declines to approve Acer Therapeutics' rare genetic disorder treatment
https://www.reuters.com/article/us-acer-therape-fda/fda-declines-to-approve-acer-therapeutics-rare-genetic-disorder-treatment-idUSKCN1TQ1K9

Jun 25th, 2019 - (Reuters) - Acer Therapeutics Inc said on Tuesday the U.S. Food and Drug Administration declined to approve its treatment for a severe, rare genetic disorder that can cause blood vessels to fatally rupture, sending its shares plunging as much as 7...

FDA declines to approve Acer Therapeutics' treatment for rare genetic disorder
https://www.reuters.com/article/acer-therape-fda/fda-declines-to-approve-acer-therapeutics-treatment-for-rare-genetic-disorder-idUSL4N23W2W3

Jun 25th, 2019 - June 25(Reuters) - Acer Therapeutics Inc said on Tuesday its treatment for a severe, rare genetic disorder that can cause blood vessels to fatally rupture was declined approval from the U.S. Food and Drug Administration. The treatment, Edsivo, aim...

Mutations Distinguish Overlapping Aortic Aneurysm Syndromes
https://www.medpagetoday.com/cardiology/acutecoronarysyndrome/3989

Aug 24th, 2006 - Action Points When treating patients with aortic-aneurysm genetic disorders, recognize that DNA genotyping for Marfan's and the two other syndromes described here will be most useful in patients who have features shared by several syndromes. When ...

see more →

Patient Education  1 results see all →